Dimensional Fund Advisors’s Satsuma Pharmaceuticals STSA Stock Holding History
Bought
Maintained
Sold
Other funds holding STSA
BCM
LPC
Dimensional Fund Advisors's STSA Position: Q1 2023 in Review
Dimensional Fund Advisors sold out of Satsuma Pharmaceuticals (STSA) in Q1 2023, closing a stake of 231,417 shares — an estimated $209K sold.
Dimensional Fund Advisors first reported a position in STSA in Q1 2021 and held it in 8 quarters. The position peaked at $1.66M in Q3 2022. 31 funds tracked by Wall St. Rank hold STSA as of Q1 2023.
- Dimensional Fund Advisors reported no remaining Satsuma Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
- Dimensional Fund Advisors sold 231,417 Satsuma Pharmaceuticals shares in Q1 2023, an estimated $209K.
- Dimensional Fund Advisors first reported a position in Satsuma Pharmaceuticals in Q1 2021 and held it in 8 quarters.
- Dimensional Fund Advisors's Satsuma Pharmaceuticals position peaked at $1.66M in Q3 2022.
- 31 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals as of Q1 2023.
Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.